From in vitro studies using human SH-SY5Y neuronal cells, it was demonstrated that cell proliferation is increased with GLP-1 treatment (Li et al., 2010
Body composition analysis: DEXA scan or bioimpedance testing
These data, when added to the growing evidence, demonstrate the potential of [glucagon-like peptide-1 receptor agonists] as a novel treatment for alcohol use disorder, wrote lead study author Mette Kruse Klausen, MD, of Mental Health Centre Copenhagen, Copenhagen University HospitalBispebjerg and Frederiksberg, and colleagues
The report, published Thursday in the medical journal JAMA Ophthalmology, found that five out of 25,330 patients studied, or less than 0.02%, of those who took Ozempic and Wegovy, also known as GLP-1 drugs, developed non-arteritic anterior ischemic optic neuropathy, or NAION, a sudden loss of vision in one eye